in summary , as a means of providing long-term disease-free survival and possible cure , bmt should be considered for children with all presenting poor-prognostic features , particularly certain chromosomal translocations [ t ( 4 ; 11 ) , t ( 9 ; 22 ) ] , very high wbc counts , notably if associated with a non-t immunophenotype , and , perhaps , a poor response to initial therapy with corticosteroids ( cs ) , or infants less than 6 months of age .
C0008059
children
C0021270
infants